medtech company that specializes in developing prescription digital therapeutics for lifestyle-related conditions.
Vitadio has raised €3.0M across 1 funding round from 2 investors, most recently a round in Oct 2023. Based in Prague, Czech Republic; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-24 | Other | €3.0M |
| Jafam Holding,Theras Group |
| View deal → |
